Results 171 to 180 of about 303,092 (316)

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

RESPIRE Score: Derivation and Validation of a New Risk Score for Prediction of Community-acquired Pneumonia Caused by Resistant Pathogens. [PDF]

Open Forum Infect Dis
Pelagatti L, De Marco M, Bosco E, Catalucci T, Gilardoni M, Mangani F, Spinicci M, Bartoloni A, Rossolini GM, Nazerian P, Vanni S.   +10 more
europepmc   +1 more source

On near derivations [PDF]

Proceedings of the American Mathematical Society, 1981
openaire   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

Molecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, Mara S Serafini, Qiang Zhang, Youbin Zhang, Lorenzo Gerratana, Andrew A. Davis, Huiping Liu, William J Gradishar, Carolina Reduzzi, Massimo Cristofanilli, Evi Lianidou   +12 more
wiley   +1 more source

Preference programming and inconsistent interval matrices

The problem of derivation of the weights of altematives from pairwise comparison matrices is long standing. In this paper,Lexicographic Goal Programming (LGP) has been used to find out weights from pairwise inconsistent interval judgment matrices.
Biswal, MP, Islam, R, Alam, SS
core  

Δ-β2M as a dynamic biomarker for predicting ICU admission after CAR T-cell therapy. [PDF]

Ann Hematol
Angleitner AC, Maulhardt M, Thomson K, Büntzel J, Wulf G.   +4 more
europepmc   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

Qualified prediction system for allograft failure in real world settings: extended validation study. [PDF]

BMJ Med
Raynaud M, Truchot A, Naser S, Aubert O, Divard G, Thalamas T, Lombardi Y, Legendre C, Bailly E, Buchler M, Crespo M, Redondo D, Astor BC, Mandelbrot D, Parajuli S, Juric I, Basic-Jukic N, Helanterä I, Evans RDR, Sanghera A, Javed M, Molnar MZ, Yamauchi J, Fornadi K, Linhares K, Baujard M, Fowler KJ, Akalin E, Gupta G, Soler Pujol G, Tedesco-Silva H, Orandi BJ, Naesens M, Budde K, Naik M, Hertig A, Anglicheau D, Kamar N, Segev DL, Lefaucheur C, Loupy A.   +40 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Development and external validation of an ICU mortality prediction model using routinely collected clinical data. [PDF]

Medicine (Baltimore)
Zhu J, Xie Z, Liu J, Li C.
europepmc   +1 more source